ArticleBreast cancer research : BCR2010

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.

Shahab Akhoondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.